• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
50,865.93 926.15
(1.85%)
Dow Jones
7,414.60 126.61
(1.74%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,316.43 61.62
(0.60%)
Forex
USD-INR
95.34 -0.07
(-0.08%)
EUR-INR
110.08 -0.10
(-0.09%)
GBP-INR
127.59 -0.01
(-0.01%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
338.0498657
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
41.44
39230.41
EPS(TTM)
Face Value()
Div & Yield %
75.78
2
0.89
 

Ajanta Pharma consolidated net profit rises 18.40% in the March 2026 quarter
May 05,2026
Net profit of Ajanta Pharma rose 18.40% to Rs 266.70 crore in the quarter ended March 2026 as against Rs 225.26 crore during the previous quarter ended March 2025. Sales rose 21.47% to Rs 1421.64 crore in the quarter ended March 2026 as against Rs 1170.41 crore during the previous quarter ended March 2025.

For the full year,net profit rose 14.73% to Rs 1056.00 crore in the year ended March 2026 as against Rs 920.39 crore during the previous year ended March 2025. Sales rose 17.31% to Rs 5452.86 crore in the year ended March 2026 as against Rs 4648.10 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1421.641170.41 21 5452.864648.10 17
OPM %23.4525.39 -25.5827.10 -
PBDT392.48309.19 27 1550.791333.27 16
PBT347.11269.41 29 1377.651189.16 16
NP266.70225.26 18 1056.00920.39 15